NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

flipper, you wrote:

They do not have PFS results at this time and the company is still blinded.
They are still waiting for 233 OS events, and they assume/surmise there are "well over" 100 patients alive.

1. So if NWBO continues to indicate that they have no PFS results at this time (and company still blinded), then is it your opinion that Pyrr's comments in his posts 114592 and 114599 are completely false?
(as it relates to his comments about 100% certainty that the P3 study has without a doubt failed primary PFS endpoint in 2016 ... and that management was informed of this ... and that they were informed it would be futile to continue ... and that the same was reported to regulatory bodies, including FDA)?

2. I had assumed that NWBO would know exactly how many patients remain alive. From your statement "they assume/surmise there are "well over" 100 patients alive" ... this could mean that perhaps 105 patients or 110 patients are still alive & that NWBO does not have an exact number.
Which would mean that 7 or 12 OS events would still need to occur before crossing the OS event threshold?
Which puts some doubt in my mind whether NWBO can accurately predict that to get to this event threshold "should only be a matter of a few/couple months".
And my concern with that is whether the company can stay afloat financially for more that just a month or two?
This concern is heightened with your post that you have the impression that the visits to all the various worldwide treatment locations might not be completed in May.